Presentation of Acute Pancreatitis After Initiation of Phentermine/Topiramate for Weight Loss: An Adverse Drug Event Case Report.

J Pharm PractJan 20, 2026 (epub)

Michelle Balli

✦ AI-curated · Sources linked

Case in brief

A 71-year-old man developed sudden mid-epigastric pain, nausea, and vomiting about 4 days after starting extended-release phentermine/topiramate for weight loss. Imaging confirmed acute pancreatitis. Gallstones, alcohol intake, and hypertriglyceridemia were ruled out as contributory factors. The medication was discontinued; symptoms improved within 2 days, and lipase was normal at discharge. A Naranjo adverse drug reaction score of 6 indicated a probable relationship to the medication, although the report describes a single case.

What made this case unusual

The report describes acute pancreatitis shortly after initiation of phentermine/topiramate, a combination product for which the authors had not found prior reports of pancreatitis.

Diagnostic / clinical pearl

When acute pancreatitis follows initiation of a medication, assess other contributory factors and consider the temporal relationship; here, the Naranjo score supported a probable drug-related event.

Source

Published in J Pharm Pract. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.